Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report.

Ozeki K, Tanida S, Mizushima T, Mizoshita T, Tsukamoto H, Hirata Y, Murakami K, Shimura T, Kataoka H, Kamiya T, Joh T. Combination therapy with adalimumab plus intensive granulocyte and monocyte adsorptive apheresis induced clinical remission in a Crohn's disease patient with the loss of response to scheduled adalimumab maintenance therapy: a case report. Intern Med. 2012; 51(6):595-9.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.